Clinical Trial Update: Pharmacogenomics of Antiplatelet Response - II (PARes-II) [Phase 4]

View source ↗

Summary

This clinical trial update reports results from PARes-II, a Phase 4 pharmacogenomics study of antiplatelet response in patients with atherothrombosis; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherothrombosis

Snippet

Sponsor: Johns Hopkins University | Conditions: Atherothrombosis | Phase 4 | Status: COMPLETED | Results posted: 2017-01-09